Associations of cardiovascular-kidney-metabolic syndrome stages with premature mortality and the role of social determinants of health
- PMID: 39952015
- PMCID: PMC12180020
- DOI: 10.1016/j.jnha.2025.100504
Associations of cardiovascular-kidney-metabolic syndrome stages with premature mortality and the role of social determinants of health
Abstract
Objectives: The American Heart Association defined cardiovascular-kidney-metabolic (CKM) syndrome as a novel multi-stage disorder. We examined the associations of CKM stages with premature mortality and the role of social determinants of health (SDOHs).
Design: A prospective cohort study.
Setting and participants: A nationally representative sample of US adults from NHANES 1999-2018.
Measurements: CKM included 5 stages (stages 0-4), reflecting progressive pathophysiology. Premature mortality (deaths before 75 years) were ascertained via linkage to the National Death Index with follow-up until 2019. Cox proportional-hazards models adjusted for age, sex, race/ethnicity, medical history, and other confounding factors were used to calculate the hazard ratios (HR) and 95% CIs for CKM-mortality associations.
Results: Among 27,909 participants (mean age 49.7 years, 49.0% females), 1762 premature deaths occurred over a median follow-up of 8.3 years. Compared with stage 0, the adjusted HRs for all-cause premature mortality at CKM stages 1-4 were 0.88 (95% CI 0.66-1.17), 1.31 (0.99-1.73), 1.94 (1.31-2.87), and 2.19 (1.61-2.98), respectively. For CVD premature mortality, the adjusted HRs for CKM stages 1-4 were 1.12 (0.46-2.72), 1.74 (0.71-4.28), 3.93 (1.53-10.12), and 6.48 (2.95-14.20), respectively. Among adults at CKM stages 3-4, unfavorable SDOHs, particularly not living with a partner, low family income, lack of private health insurance, unemployment, or ≥2 cumulative SDOHs (4.16, 95% CI 3.35-5.18) were associated with increased all-cause premature mortality. Among those at CKM stages 0-2, unfavorable SDOHs were also related to increased premature mortality.
Conclusion: CKM stages 3-4, but not stages 1-2, were associated with increased risks of premature mortality compared with stage 0. The risks were increased by unfavorable SDOHs across CKM stages.
Keywords: Cardiovascular disease; Cardiovascular–kidney–metabolic health; Diabetes; Health disparities; Obesity.
Copyright © 2025 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.
Figures



Similar articles
-
Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages by Social Determinants of Health.JAMA Netw Open. 2024 Nov 4;7(11):e2445309. doi: 10.1001/jamanetworkopen.2024.45309. JAMA Netw Open. 2024. PMID: 39556396 Free PMC article.
-
Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3: a prospective cohort study of 282,920 participants in the UK Biobank.Cardiovasc Diabetol. 2025 Jul 10;24(1):277. doi: 10.1186/s12933-025-02842-1. Cardiovasc Diabetol. 2025. PMID: 40640813 Free PMC article.
-
Cardiovascular-kidney-metabolic syndrome and all-cause and cardiovascular mortality: A retrospective cohort study.PLoS Med. 2025 Jun 26;22(6):e1004629. doi: 10.1371/journal.pmed.1004629. eCollection 2025 Jun. PLoS Med. 2025. PMID: 40570007 Free PMC article.
-
Smoking cessation for secondary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD014936. doi: 10.1002/14651858.CD014936.pub2. Cochrane Database Syst Rev. 2022. PMID: 35938889 Free PMC article.
-
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2. Cochrane Database Syst Rev. 2022. PMID: 35199850 Free PMC article.
Cited by
-
Independent associations of social determinants of health with mortality and added predictive value beyond life's essential 8.J Health Popul Nutr. 2025 Aug 11;44(1):286. doi: 10.1186/s41043-025-01038-3. J Health Popul Nutr. 2025. PMID: 40790608 Free PMC article.
-
Association of neutrophil/high-density lipoprotein cholesterol ratio with the cardiovascular-kidney-metabolic syndrome and its cardiovascular mortality.Front Nutr. 2025 Jun 4;12:1594041. doi: 10.3389/fnut.2025.1594041. eCollection 2025. Front Nutr. 2025. PMID: 40535046 Free PMC article.
-
Prediction of depression risk in middle-aged and elderly Cardiovascular-Kidney-Metabolic syndrome patients by social and environmental determinants of health: an interpretable machine learning approach using longitudinal data from China.J Health Popul Nutr. 2025 Jun 4;44(1):187. doi: 10.1186/s41043-025-00897-0. J Health Popul Nutr. 2025. PMID: 40468457 Free PMC article.
-
Association between the life's essential 8 health behaviors score and all-cause mortality in cardiovascular-kidney-metabolic syndrome patients.Front Nutr. 2025 Jun 27;12:1612693. doi: 10.3389/fnut.2025.1612693. eCollection 2025. Front Nutr. 2025. PMID: 40655481 Free PMC article.
-
Association between baseline cardio-kidney-metabolic syndrome, its transition and cognitive impairment: result from CHARLS study.Diabetol Metab Syndr. 2025 Jun 13;17(1):211. doi: 10.1186/s13098-025-01779-5. Diabetol Metab Syndr. 2025. PMID: 40514737 Free PMC article.
References
-
- Chen A., He Q., Wu Y., Chen J., Ma X., Hu L., et al. Incidence of cardiovascular-kidney-metabolic syndrome and its risk factors for progression in China. medRxiv. 2024 doi: 10.1101/2024.08.07.24311650. 2024.08.07.24311650. - DOI
-
- Diseases G.B.D., Injuries C. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2133–2161. doi: 10.1016/S0140-6736(24)00757-8. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous